In silico Prediction of Peptide based Vaccine against Fowlpox Virus (FPV)


In silico Prediction of Peptide based Vaccine against Fowlpox Virus (FPV)

Fowlpox virus (FPV) is double stranded DNA virus and a member of Poxviridae family which transmitted via aerosols and insect bite and causes cutaneous and diphtheritic infection in poultry population. This study aimed to design peptide vaccine by selecting all possible epitopes after analyzing of all FPV140 protein sequence reported in NCBI database using in silico approaches. After alignment of retrieved sequence the conserved region applied into IEDB analysis tool to predict B and T cell epitopes, then testing the affinity of predicted epitopes to bind to (BF2*2101) (BF2*0401) chicken receptor for MHC1 molecule, peptides low energy when docked against receptor were suggested as epitopes based vaccine. Peptides (50 PPSPKP 55, 51 PSPKPL 56, 52 SPKPLP 57, 53 PKPLPK 58, 54 KPLPKS 59, 55 PLPKSK 60, 56 LPKSKQ 61 and 18 RPSSTV 23) were most potential B cell epitopes while (110 YIMDNAEKL 118, 274 FYHRMYYPL 282, 278 MYYPLFSVF 286 231 YVVDNDRYV 239 and 317 LLSGVFLAY 325) docked epitopes suggested to be T cell epitopes because of their good binding affinity especially this overlapped one 110 YIMDNAEKL 118. This study concluded that those predicted epitopes might use to produce good vaccine against FPV after in vitro and in vivo studies to evaluate its efficiency.

To know more about the article:

A standard editorial manager system is utilized for manuscript submission, review, editorial processing and tracking which can be securely accessed by the authors, reviewers and editors for monitoring and tracking the article processing. Manuscripts can be uploaded online at Editorial Tracking System ( or forwarded to the Editorial Office at:

How we work:

  • After submission, an acknowledgement with manuscript number is sent to the corresponding author within 7 working days.
  • A 21 day window time frame is allotted for peer-review process wherein multiple experts are contacted.
  • Author proof is generated within 7 working days after the acceptance decision.

Benefits on Publication:

Open Access: Permanent free access to your article upon publication ensures extensive global reach and readership.

Easy Article Sharing: Our open access enables you to share your article directly with colleagues through email and on social media via a single link, permitting third party reuse with appropriate citation in addition to the retention of content copyright by the author.

Global Marketing: Through promotion in a targeted global email announcement or press release, your article will be seen by thousands of the top-most thought-leaders in your field.

Reprints: Distribute your work to colleagues and at conferences as we provide hard copy color reprints of your article on order.

Media Contact:
Stella M
Journal Manager
Immunome Research